T1	Participants 203 463	patients with an enhanced risk of bleeding, major bleeding was significantly more common during the intermittent use of heparin; in patients without these risk factors, hemorrhage occurred with equal frequency during intermittent and continuous heparin therapy
T2	Participants 44 198	Patients with pulmonary embolism or deep venous thrombosis were randomly assigned to receive either intermittent or continuous intravenous heparin therapy
